Ethicon Launches VISTASEAL Fibrin Sealant (Human) for Sealing Off Bleeds During Surgery

 Ethicon Launches VISTASEAL Fibrin Sealant (Human) for Sealing Off Bleeds During Surgery

Ethicon Launches VISTASEAL Fibrin Sealant (Human) for Sealing Off Bleeds During Surgery

Shots:

  • J&J’s Ethicon has launched VISTASEAL Fibrin Sealant (Human) for providing aid to surgeons to manage bleeding during surgery and is designed applied on the bleeding site to quickly seal off and control excessive bleeding during open surgeries or minimally invasive procedures
  • VISTASEAL was developed by Grifols and licensed it to Ethicon under a strategic collaboration which combines Ethicon’s expertise in developing device technology with Grifols’ ability to produce critical plasma-based therapies
  • VISTASEAL comprises the combination of fibrinogen and thrombin, clotting proteins found in human plasma, available in pre-filled syringes and has demonstrated a lower overall hemostatic retreatment rate (0.9%-7.8%) vs standard treatments (8.0%-16.7%)

Click here to­ read full press release/ article | Ref: JNJ Image: JNJ Medical Device

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post